Xiaowei Chang - 07 Jun 2023 Form 4 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Xiaowei Chang
Issuer symbol
N/A
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 16:11:55 UTC
Previous filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMAM Cash-Settled RSU's Award $0 -85,000 -50% $0.000000 85,000 07 Jun 2023 Ordinary Shares 85,000 Direct F1, F2
transaction AMAM Cash-Settled RSU's Award $0 -125,000 -50% $0.000000 125,000 07 Jun 2023 Ordinary Shares 125,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (the "RSUs") payable solely in cash based on the market price of the underlying Ordinary Shares on the vesting date (the reporting person will never receive the Ordinary Shares).
F2 The RSUs vest on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.
F3 The RSUs vest in three (3) successive equal annual installments following June 8, 2023.